Laparoscopic Gastrojejunostomy with Conversion Therapy in Gastric Outlet Obstruction Caused by Incurable Advanced Gastric Cancer

References

• DijksterhuisWPM, PruijtMJ, van der WoudeSO, et al. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle. 2019;10(1):199–206. doi:10.1002/jcsm.1237130666831
   PubMed Web of Science ®Google Scholar
• SolainiL, MinistriniS, BencivengaM, et al. Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study. Gastric Cancer. 2019;22(6):1285–1293. doi:10.1007/s10120-019-00968-231065878
   PubMed Web of Science ®Google Scholar
• MinistriniS, BencivengaM, SolainiL, et al. Stage IV gastric cancer: the surgical perspective of the Italian research group on gastric cancer. Cancers. 2020;12(1). doi:10.3390/cancers12010158.
   PubMed Web of Science ®Google Scholar
• YoshidaK, YamaguchiK, OkumuraN, TanahashiT, KoderaY. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19(2):329–338. doi:10.1007/s10120-015-0575-z26643880
   PubMed Web of Science ®Google Scholar
• ZhangF, HuangX, SongY, et al. Conversion Surgery for Stage IV Gastric Cancer. Front Oncol. 2019;9:1158. doi:10.3389/fonc.2019.0115831788445
   PubMed Web of Science ®Google Scholar
• HagaY, HikiN, KinoshitaT, et al. Treatment option of endoscopic stent insertion or gastrojejunostomy for gastric outlet obstruction due to gastric cancer: a propensity score-matched analysis. Gastric Cancer. 2020;23(4):667–676. doi:10.1007/s10120-020-01040-031982964
   PubMed Web of Science ®Google Scholar
• TanakaT, SudaK, SatohS, et al. Effectiveness of laparoscopic stomach-partitioning gastrojejunostomy for patients with gastric outlet obstruction caused by advanced gastric cancer. Surg Endosc. 2017;31(1):359–367. doi:10.1007/s00464-016-4980-027287913
   PubMed Web of Science ®Google Scholar
• JangS, StevensT, LopezR, BhattA, VargoJJ. Superiority of Gastrojejunostomy Over Endoscopic Stenting for Palliation of Malignant Gastric Outlet Obstruction. Clin Gastroenterol Hepatol. 2019;17(7):1295–1302.e1291. doi:10.1016/j.cgh.2018.10.04230391433
   PubMed Web of Science ®Google Scholar
• DongJ, ZhangW, ZhangT, et al. Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy. Ann Transl Med. 2020;8(18):1148. doi:10.21037/atm-20-407833240997
   PubMed Web of Science ®Google Scholar
• ArendsJ, BachmannP, BaracosV, et al. ESPEN guidelines on nutrition in cancer patients. Clin nutr. 2017;36(1):11–48.27637832
   PubMed Web of Science ®Google Scholar
• LiYF, NieRC, WuT, et al. Prognostic Value of the Nutritional Risk Screening 2002 Scale in Metastatic Gastric Cancer: a Large-Scale Cohort Study. J Cancer. 2019;10(1):112–119. doi:10.7150/jca.2772930662531
   PubMed Web of Science ®Google Scholar
• PalmelaC, VelhoS, AgostinhoL, et al. Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer. J Gastric Cancer. 2017;17(1):74–87. doi:10.5230/jgc.2017.17.e828337365
   PubMed Web of Science ®Google Scholar
• Gomez-PerezSL, HausJM, SheeanP, et al. Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: a Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr. 2016;40(3):308–318. doi:10.1177/014860711560414926392166
   PubMed Web of Science ®Google Scholar
• MimatsuK, FukinoN, OgasawaraY, SainoY, OidaT. Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery. Anticancer Res. 2017;37(8):4215–4222.28739709
   PubMed Web of Science ®Google Scholar
• YoshidaN, BabaY, ShigakiH, et al. Preoperative Nutritional Assessment by Controlling Nutritional Status (CONUT) is Useful to estimate Postoperative Morbidity After Esophagectomy for Esophageal Cancer. World J Surg. 2016;40(8):1910–1917. doi:10.1007/s00268-016-3549-327220507
   PubMed Web of Science ®Google Scholar
• TerashimaM, FujitaniK, AndoM, et al. Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. Gastric Cancer. 2021;24(1):224–231. doi:10.1007/s10120-020-01114-z32789710
   PubMed Web of Science ®Google Scholar
• PulenzasN, KhanL, TsaoM, et al. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy. Supportive Care Cancer. 2014;22(7):1757–1763. doi:10.1007/s00520-014-2140-4
   PubMed Web of Science ®Google Scholar
• SatoY, OhnumaH, NobuokaT, et al. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study. Gastric Cancer. 2017;20(3):517–526. doi:10.1007/s10120-016-0633-127553665
   PubMed Web of Science ®Google Scholar
• ZhouC, MaT, ShiM, et al. Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach. Cancer Chemother Pharmacol. 2020;85(1):113–119. doi:10.1007/s00280-019-03982-431691079
   PubMed Web of Science ®Google Scholar
• ProvenzaleD, GuptaS, AhnenDJ, et al. Genetic/Familial High-Risk Assessment: colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Nat Comprehensive Cancer Network. 2016;14(8):1010–1030. doi:10.6004/jnccn.2016.0108
   PubMed Web of Science ®Google Scholar
• FujitaniK, YangHK, MizusawaJ, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a Phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309–318. doi:10.1016/S1470-2045(15)00553-726822397
   PubMed Web of Science ®Google Scholar
• HillerJG, PerryNJ, PoulogiannisG, RiedelB, SloanEK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–218. doi:10.1038/nrclinonc.2017.19429283170
   PubMed Web of Science ®Google Scholar
• KrallJA, ReinhardtF, MercuryOA, et al. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumours in mouse models of dormancy. Sci Transl Med. 2018;10:436. doi:10.1126/scitranslmed.aan3464
   Web of Science ®Google Scholar
• LangePH, HekmatK, BoslG, KennedyBJ, FraleyEE. Acclerated growth of testicular cancer after cytoreductive surgery. Cancer. 1980;45(6):1498–1506. doi:10.1002/1097-0142(19800315)45:6<1498::AID-CNCR2820450633>3.0.CO;2-76153570
   PubMed Web of Science ®Google Scholar
• MinSH, SonSY, JungDH, et al. Laparoscopic gastrojejunostomy versus duodenal stenting in unresectable gastric cancer with gastric outlet obstruction. Ann Surg Treatment Res. 2017;93(3):130–136. doi:10.4174/astr.2017.93.3.130
   PubMed Web of Science ®Google Scholar
• MengQ, TanS, JiangY, et al. Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: a randomized clinical trial. Clin nutr. 2021;40(1):40–46.32563598
   PubMed Web of Science ®Google Scholar
• SeoSH, KimS-E, KangY-K, et al. Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients. BMC Cancer. 2016;16(1):900. doi:10.1186/s12885-016-2934-527863481
   PubMed Web of Science ®Google Scholar
• ArendsJ. Struggling with nutrition in patients with advanced cancer: nutrition and nourishment-focusing on metabolism and supportive care. Ann Oncol. 2018;29(suppl_2):ii27–ii34. doi:10.1093/annonc/mdy093
   Google Scholar
• SchörghuberM, FruhwaldS. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill. Lancet Gastroenterol Hepatol. 2018;3(4):281–287. doi:10.1016/S2468-1253(18)30036-029533200
   PubMed Web of Science ®Google Scholar
• BlayneyDW, ZhangQ, FengJ, et al. Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2020;6:11. doi:10.1001/jamaoncol.2020.4429
   Web of Science ®Google Scholar
• AoyamaT, KawabeT, FujikawaH, et al. Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22(8):2560–2566. doi:10.1245/s10434-014-4296-z25515199
   PubMed Web of Science ®Google Scholar
• MigitaK, MatsumotoS, WakatsukiK, et al. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy. Surg Today. 2017;47(8):1018–1026. doi:10.1007/s00595-017-1469-y28251372
   PubMed Web of Science ®Google Scholar
• AwadS, TanBH, CuiH, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin nutr. 2012;31(1):74–77. doi:10.1016/j.clnu.2011.08.00821875767
   PubMed Web of Science ®Google Scholar
• TanBH, BrammerK, RandhawaN, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur j Surg Oncol. 2015;41(3):333–338. doi:10.1016/j.ejso.2014.11.04025498359
   PubMed Web of Science ®Google Scholar
• RyanAM, PowerDG, DalyL, CushenSJ, Ní BhuachallaĒ, PradoCM. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199–211. doi:10.1017/S002966511500419X26786393
   PubMed Web of Science ®Google Scholar
• SanoT, SasakoM, YamamotoS, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy–Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22(14):2767–2773. doi:10.1200/JCO.2004.10.18415199090
   PubMed Web of Science ®Google Scholar